Pacific Biosciences Of California (PACB) Finished Goods (2011 - 2026)

Pacific Biosciences Of California's Finished Goods history runs 16 years deep, the most recent figure standing at $17.8 million for Q1 2026.

• In Q1 2026, Finished Goods rose 32.83% year-over-year to $17.8 million; the TTM figure through Mar 2026 stood at $17.8 million (up 32.83% YoY), while the FY2025 annual figure was $15.7 million, up 11.56% from the prior year.
• Finished Goods was $17.8 million for Q1 2026 at Pacific Biosciences Of California, up from $15.7 million in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $19.8 million in Q2 2023 to a low of $7.9 million in Q2 2022.
• Historically, Finished Goods has averaged $14.6 million across 5 years, with a median of $15.7 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Finished Goods surged 151.65% in 2023, then retreated 18.18% in 2025.
• A 5-year view of Finished Goods shows it stood at $12.2 million in 2022, then climbed by 29.28% to $15.7 million in 2023, then dropped by 10.57% to $14.1 million in 2024, then gained by 11.56% to $15.7 million in 2025, then climbed by 13.55% to $17.8 million in 2026.
• The last three Finished Goods figures came in at $17.8 million (Q1 2026), $15.7 million (Q4 2025), and $16.4 million (Q3 2025), per Business Quant data.